Photochemotherapy of vascular cells with 8-methoxypsoralen and visible light: Differential effects on endothelial and smooth muscle cells

Photodermatology Photoimmunology and Photomedicine

Volumn 18, Issue 5, 2002, Pages 244-252

  Lee, David M ^a   Gasparro, Francis P ^a   Wang, Xiu Jie ^a   Kopec, Chris ^a   DeLeo, Kier ^a   Sumpio, Bauer E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

8 MOP; Phototherapy; Vascular cells

Indexed keywords

METHOXSALEN; POLYSTYRENE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ASSAY; CELL COUNT; CELL MIGRATION; CELL PROLIFERATION; CELL SIZE; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSTASIS; ENDOTHELIUM CELL; INCUBATION TIME; NONHUMAN; PHOTOACTIVATION; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; RADIATION EXPOSURE; SMOOTH MUSCLE FIBER; ANALYSIS OF VARIANCE; ANIMAL; CATTLE; CELL CULTURE; CELL DIVISION; CELL MOTION; CYTOLOGY; DRUG EFFECT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHODOLOGY; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; CATTLE; CELL DIVISION; CELL MOVEMENT; CELL SIZE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; METHOXSALEN; MUSCLE, SMOOTH, VASCULAR; PHOTOCHEMOTHERAPY;

EID: 0036809572     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2002.02770.x     Document Type: Article

References (31)

1. Sumpio BE, Phan SM, Gasparro FP, Deckelbaum LI. Control of smooth muscle cell proliferation by psoralen photochemotherapy. J Vasc Surg 1993; 17: 1010-1016.
2. Ip JH, Fuster V, Israel D, et al. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667-1687.
3. Hermans WRM, Rensing BJ, Strauss BH, Serruys PW. Prevention of restenosis after percutaneous transluminal coronary angioplasty: the search for a 'magic bullet'. Am Heart J 1991; 122: 171-18 7.
4. Nobuyoshi M, Kimura T, Ohishi H, et al. Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients. J Am Coll Cardiol 1991; 17: 433-439.
5. Serruys PW, Luijten HE, Beatt KJ, et al. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988; 77: 361-371.
6. Forrester IS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. J Am Coll Cardiol 1991; 17: 758-769.
7. Ip JH, Fuster V, Israel D, Badimon L, Badimon J, Chesebro JH. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol 1991; 17: 77B-88B.
8. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Laboratory Med 1992; 116: 1292-1300.
9. Bayley H, Gasparro FP, Edelson RL. Light Activated Drugs. Trends Pharmaceut Sci 1987; 8: 138-143.
10. Ortu P, LaMuraglia GM, Roberts WG, Flotte TJ, Hasan T. Photodynamic therapy of arteries: a novel approach for treatment of experimental intimal hyperplasia. Circulation 1992; 85: 1189-1196.
11. Eton D, Coburn MD, Shim V, et al. Inhibition of intimal hyperplasia by photodynamic therapy using photofrin. J Surg Res 1992; 53: 558-562.
12. Dartsch PC, Ischinger T, Betz E. Differential effect of photofrin II on growth of human smooth muscle cells from non-atherosclerotic arteries and atheromatous plaques in vitro. Arteriosclerosis 1990; 10: 616-624.
13. Dartsch PC, Ischinger T, Betz E. Response of cultured smooth muscle cells from human non-atherosclerotic arteries and primary stenosing lesions after photoradiation: implications for photodynamic therapy of vascular stenoses. J Am Coll Cardiol 1990; 15: 1545-1550.
14. LaMuralgia GM, ChandraSekar NR, Flotte TJ, Abbott WM, Michaud N, Hasan T. Photodynamic therapy inhibition of experimental hyperplasia: acute and chronic effects. J Vasc Surg 1994; 19: 321-331.
15. March KL, Patton BL, Wilensky RL, Hathaway DR. 8-Methoxypsoralen and longwave ultraviolet irradiation are a novel antiproliferative combination for vascular smooth muscle. Circulation 1993; 87: 184-191.
16. Gasparro FP, Gattolin P, Olack GA, Deckelbaum LI, Sumpio BE. The excitation of 8-methoxypsoralen with visible light: reversed phase HPLC quantitation of monoadducts and cross-links. Photochem Photobiol 1993; 57: 1007-1010.
17. Sumpio BE, Li G, Deckelbaum LI, Gasparro FP. Inhibition of smooth muscle cell proliferation by visible light-activated psoralen. Circ Res 1994; 75: 208-213.
18. Schmitt I, Maxwell VM, Olack GO, Chimenti S, Edelson RL, Gasparro FP. The specific effects of 8-methoxypsoralen photoadducts on cell survival: HPLC analysis of monoadduct and cross-link formation in cells exposed to split-dose treatment. J Photochem Photobiol 1994; B22: 17-21.
19. Parrish JA, Anderson RR, Urbach F, Pitts D. UV-A: the Biological Effects of Ultraviolet Radiation with Emphasis on Human Responses to Longwave Ultraviolet. New York: Plenun Press, 1978: 74-75.
20. Mills I, Cohen CR, Kamal K, Li G, Du W, Sumpio BE. Strain activation of bovine aortic smooth muscle cell proliferation and alignment: study of strain dependency and the role of protein kinase A and C signaling pathways. J Cell Physiol 1997; 170: 228-234.
21. Awolesi MA, Sessa WC, Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1996; 96: 1449-1454.
22. Bell L, Luthringer DJ, Madri JA, Warren SL. Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression. J Clin Invest 1992; 89: 315-320.
23. Olack GA, Gattolin P, Gasparro FP. Improved HPLC analysis of 8-methoxypsoralen monoadducts and cross-links in polynucleotide, DNA and cellular systems: analysis of split-dose protocols. Photochem Photobiol 1993; 57: 941-949.
24. Gasparro FP, ed. Extracorporeal photochemotherapy. clinical aspects and the molecular basis for efficacy. George town: RG Landes Co., Medical Intelligence Unit, 1994.
25. Krolak L, Tod M, Leon A, Heudes AM, Petitjean O, Laroche L. In vitro kinetics of 8-methoxypsoralen penetration into human lymphoid cells. Photodermatol Photoimmunol Photomed 1992; 9: 58-61.
26. Moreno G, Salet C, Koen C, Kohen E. Penetration and localization of furocoumarins in single living cells studied by microspectrofluorometry. Biochem Biophys Acta 1982; 721: 109-111.
27. Moor ACE, Gasparro FP. Biochemical aspects of psoralen photo-chemotherapy. Clinics Dermatol 1996; 14: 353-365.
28. Vallat VP, Gilleaudeau. P, Battat L, et al. PUVA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: a possible cellular basis for remittive therapy. J Exp Med 1994; 180: 283-296.
29. Gupta AK, Anderson TF. Psoralen photochemotherapy. J Am Acad Dermatol 1987; 17: 703-734.
30. Wilensky RL, March KL, Hathaway DR. Direct intraarterial wall injection of microparticles via a catheter: a potential drug delivery strategy following angioplasty. Am Heart J 1991; 122: 1136-1140.
31. Spears JR, Reyes VP, Wynne J, et al. Percutaneous coronary laser balloon angioplasty: initial results of a multicenter experience. J Am Coll Cardiol 1990; 16: 293-303.